Applied Therapeutics Inc. (NASDAQ: APLT)
$0.9286
-0.0914 ( -2.25% ) 6.0M
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Market Data
Open
$0.9286
Previous close
$1.0200
Volume
6.0M
Market cap
$101.84M
Day range
$0.8420 - $1.0150
52 week range
$0.8420 - $10.6237
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 114 | Mar 06, 2024 |
8-k | 8K-related | 19 | Feb 29, 2024 |
8-k | 8K-related | 14 | Feb 15, 2024 |
8-k | 8K-related | 12 | Jan 04, 2024 |
8-k | 8K-related | 12 | Jan 03, 2024 |
8-k | 8K-related | 13 | Dec 29, 2023 |
4 | Insider transactions | 1 | Dec 22, 2023 |
4 | Insider transactions | 1 | Dec 22, 2023 |
4 | Insider transactions | 1 | Dec 22, 2023 |
4 | Insider transactions | 1 | Dec 05, 2023 |